Chlorpheniramine Maleate 4mg
NDC Package 70692-113-41

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Chlorpheniramine Maleate 4mg is temporarily relieves the following symptoms due to hay fever or other upper respiratory allergiessneezingrunny noseitchy, watery eyesitching of the nose or throat. Marketed by Strive Pharmaceuticals Inc, this product is identified by NDC 70692-113 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
70692-113-41
Package Description
4 TABLET in 1 PACKAGE
Product Code
70692-113
11-Digit Billing Format
70692011341
RxNorm Crosswalk
RxCUI: 1363309 - chlorpheniramine maleate 4 MG Oral Tablet

Clinical Specifications

Proprietary Name
Chlorpheniramine Maleate 4mg
Dosage Form
-
Usage Information
Temporarily relieves the following symptoms due to hay fever or other upper respiratory allergiessneezingrunny noseitchy, watery eyesitching of the nose or throat

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
12-20-2018
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-113-41 identifies a specific commercial package of 4 tablet in 1 package of Chlorpheniramine Maleate 4mg, labeled by Strive Pharmaceuticals Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strive Pharmaceuticals Inc on December 20, 2018. The current certification is valid through December 31, 2021.

How is this Strive Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692011341. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-113-41
11-Digit CMS (5-4-2)
70692-0113-41

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.